Evidence map›Paper›PMID 39910879›Full record

ArticleAsia-Pacific journal of clinical oncology2025

Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and When.

Alison Luk Young, Melissa McEnallay, Fiona Day, Shalini K Vinod, Emily Stone, Sarah Morris, Elena Stefanovska, Bianca Devitt, Po Yee Yip, Craig Kukard and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia-Pacific journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Alison Luk YoungSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Melissa McEnallaySchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Fiona DaySchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.ORCID https://orcid.org/0000-0002-5905-9408
Shalini K VinodCancer Therapy Centre, Liverpool Hospital, Liverpool, New South Wales, Australia.
Emily StoneSchool of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Sarah MorrisSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Elena StefanovskaSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Bianca DevittDepartment of Medical Oncology, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
Po Yee YipMacarthur Cancer Therapy Centre, Campbelltown Hospital, South Western Sydney Local Health District, Liverpool, New South Wales, Australia.
Craig KukardSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Abhijit PalIngham Institute for Applied Medical Research, South Western Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Vaibhav ThawalSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Gavin WrightDepartment of Cardiothoracic Surgery, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Alison HofmanNorth West Cancer Centre, Tamworth Hospital, North Tamworth, New South Wales, Australia.
Heena SareenIngham Institute for Applied Medical Research, South Western Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
James McLennanSt Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Shuet Oi WongDepartment of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia.
Cassandra RubioDepartment of Medical Oncology, Central Coast Cancer Centre, Gosford Hospital, Waratah, New South Wales, Australia.
Jennifer LiuDepartment of Medical Oncology, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
Alexandra SmithNorth West Cancer Centre, Tamworth Hospital, North Tamworth, New South Wales, Australia.
Dimity BettsNorth West Cancer Centre, Tamworth Hospital, North Tamworth, New South Wales, Australia.
Jane MackDepartment of Cardiothoracic Surgery, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Jennifer DonnellyDepartment of Cardiothoracic Surgery, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Christine PaulSchool of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.ORCID https://orcid.org/0000-0002-0504-5246

Funding

Cancer Council AustraliaCancer Council VictoriaNational Health and Medical Research Council APP1169324Quit Victoria
6 · The paper itself

Abstract

purposePatients who smoke tobacco during and after a cancer diagnosis have poorer health outcomes. Oncology healthcare providers (HCPs) are crucial to providing smoking cessation support. The study examined the characteristics associated with differences in HCPs' smoking cessation practices.

methodsAs part of the Care to Quit trial, a cross-sectional survey exploring smoking cessation practices was completed by HCPs across nine cancer centers in New South Wales and Victoria, Australia.

resultsOne hundred and seventy-seven HCPs completed the survey. Over half of the HCP respondents reported asking patients their smoking status, but fewer than half advised patients about the benefits of quitting, referred patients to behavioral support such as Quitline, or offered pharmacotherapy medication. All components of the "3A's" model (Ask, Advise, Act) were more likely to be completed by doctors compared to registered nurses (OR: 7.86, 95% CI: 3.64, 16.95, p<0.001), by those with more years of practice (OR: 0.26, 95% CI: 0.07-0.93, p = 0.039), and those who had received smoking cessation training (OR: 3.91, 95% CI: 1.80, 8.48, p = 0.001). Multivariate analyses also identified differences in the amount of cancer-specific advice provided between occupation type (p<0.001) and years of practice (p = 0.021).

conclusionThe need for smoking cessation care training in oncology continues to be apparent. Training in prescribing pharmacotherapies (for doctors) or supporting the use of pharmacotherapies (for nurses) is a particular "gap." Differences between the roles and engagement of doctors and nurses in relation to smoking cessation care should be carefully considered when developing site-specific models of cessation care and providing training.

Indexed as

nursingoncologysmokingsmoking cessationsurveytobacco

Identifiers

PMID39910879
PMCPMC12033037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.